TrialJAMA ophthalmology2021

Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial.

David M Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.